Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France
Author:
Funder
Amgen
Roche
Eisai
Celgene
Bristol-Myers Squibb
IntegraGen
Invectys
Merck Serono
Nestlé
Novartis
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference30 articles.
1. Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Moreau;Ann Oncol,2013
2. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN);Palumbo;Blood,2011
3. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008
4. Current treatment landscape for relapsed and/or refractory multiple myeloma;Dimopoulos;Nat Rev Clin Oncol,2015
5. Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory;Cleeland;Cancer,2000
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation—Results from the LenaMain Trial (NCT00891384);Cancers;2023-10-26
2. Treatment sequences and drug costs from diagnosis to death in multiple myeloma;European Journal of Haematology;2023-10-11
3. Post-infusion Costs Associated with Idecabtagene Vicleucel Treatment for Patients with Relapsed/Refractory Multiple Myeloma in the KarMMa Trial;Advances in Therapy;2023-08-19
4. Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study;Leukemia & Lymphoma;2023-08-04
5. Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review;Clinical Lymphoma Myeloma and Leukemia;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3